Urteste Company Description

Urteste S.A. engages in the research and development of diagnostic tests for cancers.

It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer.

The company was incorporated in 2021 and is based in Gdansk, Poland.

Urteste S.A.

Country	Poland
Founded	2021
Industry	Biotechnology
Sector	Healthcare
Employees	20
CEO	Grzegorz Stefanski

Contact Details

Address: ul. Starodworska 1 Gdansk, 80-137 Poland
Website	urteste.com

Stock Details

Ticker Symbol	URT
Exchange	Warsaw Stock Exchange
Fiscal Year	January - December
Reporting Currency	PLN
ISIN Number	PLURTST00010
SIC Code	2835

Key Executives

Name	Position
Grzegorz Stefanski	President of the Management Board
Tomasz Kostuch	Member of the Management Board